MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Bexmarilimab Plus Vidaza Elicit Responses in Myelodysplastic Syndromes

April 16th 2025, 3:05pm

Article

Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory higher-risk myelodysplastic syndrome.

Sometimes Cancer is a (Welcome) Distraction

April 8th 2025, 5:00pm

Article

In an upside-down, topsy-turvy world, cancer can be a distraction for us.

EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

March 25th 2025, 9:00pm

Article

The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.

Looking For The Light After MDS

March 6th 2025, 6:00pm

Article

As a cancer survivor, I talk about where to look for the light when in utter darkness.

Cancer is Hard Enough Without Infections

February 21st 2025, 6:00pm

Article

As a cancer survivor, I describe battling both cancer and infections and the toll it takes on my body.

Moving Slower and Slower After Myelodysplastic Syndrome

February 12th 2025, 6:00pm

Article

I have been frustrated lately by my increasing slowness following an blood cancer diagnosis, which has become noticeable to others.

Breaking Down Cancer Therapies Approved by the FDA in January 2025

February 3rd 2025, 4:00pm

Article

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.

A Phase 1 Trial of Iadademstat Plus Vidaza Has Dosed a Patient With MDS

January 29th 2025, 10:00pm

Article

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with myelodysplastic syndrome.

Life After MDS and Accomplishing Your Goals

January 28th 2025, 6:00pm

Article

After a long and difficult journey, I finally published the book I set out to write as my legacy, overcoming cancer and the challenges of deafness.

FDA Approves GRAFAPEX/Fludarabine Before alloHSCT in AML and MDS

January 24th 2025, 4:15pm

Article

The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome prior to alloHSCT.